Author
Unnikrishnan is currently Senior Associate Editor with BW Businessworld at its Mumbai Bureau. During his two decades long journalistic career, he has received several media awards and recognitions. His articles on healthcare, life sciences and intellectual property rights (IPR) have been republished by several international blogs and journals.
Even as RIL pushes ahead with its grand ambitions of becoming India’s digital behemoth, energy will continue to drive company’s growth and profits for years to come
Read More
Cipla has always fought against unjustified market monopolies by MNC giants and has boldly launched cheaper generic drugs
Read More
BPCL has not only sustained growth but also tried constant innovation in its business model to excel in the challenging market scenario
Read More
The Gujarat high court on Monday dismissed Essar Steel's petition that had challenged the RBI's directive to banks for initiating insolvency proceedings against the company. The High Court also said in oral order that, "No relief will be granted to Essar."
Read More
Several Indian corporates are eyeing a huge chunk in the aerospace manufacturing pie, traditionally dominated by government owned firms
Read More
The technology not only offers seamless communication and entertainment possibilities to passengers but also enables the airline to take informed decisions on board to save costs by energy efficient navigation, avoiding flight delays and helping on-time repair and maintenance
Read More
Armed with investment in R&D and innovation, India Inc. is now betting big on healing with herbs
Read More
Keeping up with the new format is giving the sector sleepless nights
Read More
Indian drug industry losses another doyen after Dr. Parvinder Singh, IA Modi and Ramanbhai Patel
Read More
